Expression of AXL, another member of the TAM RTK family, has been previously correlated with resistance to OSI and other EGFR TKIs, and AXL inhibition restored sensitivity to EGFR TKIs in AXL-expressing EGFRMT NSCLC cells (31, 46, 47). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.